Skip to main content

Dr. Bogdana Schmidt, MD

Urology (Urology Physician)

300 Pasteur Dr
Stanford, CA 94305

Who else practices at this address →

Santa Clara County includes mental health (13% of residents) shortage areas. About shortage areas

Call (650) 723-4000

  • Medicare participating

At a glance

Years since graduation
13
In the NPI registry since
2013
Medicare patients seen, 2024
187

Licensed in California since 2014, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2013Registered with an NPI (national billing number; not a license date)

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Urology Physician primary
    CA license A133342 (first issued 2014; delinquent)

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Urology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
187
Services billed
495
Patients’ average age
73
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes7862
Diagnostic exam of bladder and urethra using an endoscope4628
New patient office or other outpatient visit, 60-74 minutes4343
Established patient office or other outpatient visit, 40-54 minutes4039
Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm1111

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 6 companies reported 27 payments worth $18,348 in total to this clinician.

By company
Ferring Pharmaceuticals Inc.$11,534
Janssen Global Services, LLC$3,084
Intuitive Surgical, Inc.$1,659
Janssen Scientific Affairs, LLC$1,031
Janssen Biotech, Inc.$965
Coloplast Corp$75.58
By type
Consulting Fee$15,598
Education$1,500
Food and Beverage$1,134
Travel and Lodging$117

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Dec 22, 2025Ferring Pharmaceuticals Inc.
Dec 22, 2025
Consulting Fee
ADSTILADRIN · ONCOLOGY
$8,075
Nov 14, 2025Ferring Pharmaceuticals Inc.
Nov 14, 2025
Consulting Fee
ADSTILADRIN · ONCOLOGY
$2,850
Dec 5, 2025Janssen Global Services, LLC
Dec 5, 2025
Consulting Fee$2,538
Jan 17, 2025Intuitive Surgical, Inc.
Jan 17, 2025
Education
DA VINCI SP · SURGERY · in-kind
$1,500
Apr 27, 2025Janssen Biotech, Inc.
Apr 27, 2025
Consulting Fee$818
Apr 27, 2025Janssen Scientific Affairs, LLC
Apr 27, 2025
Consulting Fee$818
Apr 16, 2025Janssen Global Services, LLC
Apr 16, 2025
Consulting Fee$500
Dec 13, 2025Ferring Pharmaceuticals Inc.
Dec 13, 2025
Travel and Lodging
ADSTILADRIN · ONCOLOGY · travel to SALT LAKE CITY, UT · in-kind
$117

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in California →

Industry-funded research

Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $106,991 in research payments for these studies, mostly to the institutions running them.

  • A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder (SunRISe-4)
    Janssen Research & Development, LLC
  • ADSTILADRIN Early Utilization and Outcomes in the Real World Setting
    Ferring Pharmaceuticals As · Terminated · NCT06026332
  • A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination with Cetrelimab Versus Intravesical Bacillus CalmetteGurin (BCG) in Participants with BCG-nave High-Ri…
    Janssen Research & Development, LLC

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Urology clinicians in Stanford

Sources

NPI registry (CMS NPPES, November 2026; record last updated November 18, 2021), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1386987865. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.